Current issues in gram-negative resistance: Extended-spectrum beta-lactamases and inducible beta-lactamases

Journal of Pharmacy Practice

Volumn 14, Issue 1, 2001, Pages 6-17

  Fung, Horatio B ^a   Kuczynski, Stephen ^a   Finch, Douglas A ^a   Ramos, Liz ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b KINGSBROOK JEWISH MEDICAL CENTER   (United States)

Author keywords

Extended spectrum beta lactamases; Gram negative resistance; Inducible beta lactamases; Mechanisms of antimicrobial resistance

Indexed keywords

BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERIUM ISOLATION; ENZYME INDUCTION; ENZYME SYNTHESIS; GRAM NEGATIVE BACTERIUM; OUTCOMES RESEARCH; REVIEW;

EID: 0035038293     PISSN: 08971900     EISSN: None     Source Type: Journal    
DOI: 10.1106/HB54-F01J-R72L-FGMG     Document Type: Review

References (35)

1. Antibiotic resistance - Do we need new therapeutic approaches?
2. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics
3. Ins and outs of antimicrobial resistance: Era of the drug pumps
4. Reasons for the emergence of antibiotic resistance
5. Antimicrobial resistance: Implications for the clinician
6. The crisis in antibiotic resistance
7. Antimicrobial drug resistance
8. Microbial resistance to drug therapy: A review
9. Pathogens resistant to antimicrobial agents
10. Antibiotic resistance in bacteria
11. Bacterial resistance: New findings, new options
12. Antimicrobial resistance with focus on β-lactam resistance in gram-negative bacilli
13. The diversity structure and regulation of βlactamases
14. A functional classification scheme for β-lactamases and its correlation with molecular structure
15. Nomenclature of TEM β-lactamases
16. β-Lactamases in laboratory and clinical resistance
17. Mechanisms of bacterial antibiotic resistance
18. Metallo-β-lactamases: A class apart
19. Antimicrobial resistance: A review of emerging pathogens
20. Extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae: Clinical and therapeutic implications
21. Is it important to identify extended-spectrum beta-lactamase-producing isolates?
22. Extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom
23. Extended-spectrum β-lactamases and other enzymes providing resistance to oxyimino-β-lactams
24. Antimicrobial activity and spectrum investigation of eight broad-spectrum β-lactam drugs: A 1997 surveillance trial in 102 medical centers in the United States
25. Detection and clinical significance of extended-spectrum β-lactamases in a tertiary-care medical center
26. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins
27. Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum β-lactamase-producing strain of Klebsiella pneumoniae
28. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center
29. In vitro susceptibility and clinical outcome of bacteremia due to extended-spectrum β-lactamases (ESBL)-producing Klebsiella pneumoniae
30. Bacterial resistance: A worldwide problem
31. Antimicrobial-resistant pathogens in the 1990s
32. AmpC β-lactamases
33. Important and emerging β-lactamase-mediated resistances in hospital-based pathogens: The ampC enzymes
34. Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae